Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDUSTRY × Thymus Neoplasms × Clear all

Phase

Phase 1 3 Phase 2 1

Status

Sponsor Class

OTHER 9 NIH 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 571 Breast Neoplasms 482 Neoplasms 388 Colorectal Neoplasms 248 Prostatic Neoplasms 227 Neoplasm Metastasis 220 Melanoma 204 Recurrence 182 Ovarian Neoplasms 181 Multiple Myeloma 162 Lung Neoplasms 161 Pancreatic Neoplasms 132 Lymphoma, Non-Hodgkin 130 Leukemia, Myeloid, Acute 125 Carcinoma, Hepatocellular 121 Stomach Neoplasms 115 Lymphoma 108 Carcinoma, Renal Cell 104 Glioblastoma 101 Head and Neck Neoplasms 94 Squamous Cell Carcinoma of Head and Neck 93 Lymphoma, Large B-Cell, Diffuse 87 Lymphoma, Follicular 85 Leukemia, Lymphocytic, Chronic, B-Cell 85 Leukemia 84 Small Cell Lung Carcinoma 79 Brain Neoplasms 79 Carcinoma 67 Uterine Cervical Neoplasms 64 Sarcoma 60

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05683886 2024-10-17

A Study of KC1036 in Patients with Advanced Thymic Tumors

Beijing Konruns Pharmaceutical Co., Ltd.

Phase 2 Recruiting

Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡